Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy

Progress in Retinal and Eye Research

Volumn 45, Issue , 2015, Pages 1-29

  Whitmore, S Scott ^a,b   Sohn, Elliott H ^a,b   Chirco, Kathleen R ^a,b   Drack, Arlene V ^a,b   Stone, Edwin M ^a,b   Tucker, Budd A ^a,b   Mullins, Robert F ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Age related macular degeneration; Choriocapillaris; Choroidmacula; Complement system; Endothelial cells; Pathophysiology

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT FACTOR H; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT;

AGE RELATED MACULAR DEGENERATION; AGING; BRUCH MEMBRANE; CHOROID CAPILLARY LAYER; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; DRUSEN; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GEOGRAPHIC ATROPHY; HISTOLOGY; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEOMICS; REVIEW; THERMOREGULATION; CHOROID; GENETICS; IMMUNOLOGY; MACULAR DEGENERATION; PHYSIOLOGY; RETINAL PIGMENT EPITHELIUM; VASCULARIZATION;

AGING; BRUCH MEMBRANE; CHOROID; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; MACULAR DEGENERATION; RETINAL PIGMENT EPITHELIUM;

EID: 84925356256     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2014.11.005     Document Type: Review

References (342)

1. Abi-Hanna D., Wakefield D., Watkins S. HLA antigens in ocular tissues. I. Invivo expression in human eyes. Transplantation 1988, 45:610-613.
2. Ablonczy Z., Dahrouj M., Marneros A.G. Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels. FASEB J. 2014, 28:2369-2379. 10.1096/fj.13-248021.
3. Ach T., Huisingh C., McGwin G., Messinger J.D., Zhang T., Bentley M.J., Gutierrez D.B., Ablonczy Z., Smith R.T., Sloan K.R., Curcio C.A. Quantitative autofluorescence and cell density maps of the human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2014, 55:4832-4841. 10.1167/iovs.14-14802.
4. Lutein+zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013, 309:2005-2015. Age-Related Eye Disease Study 2 Research Group. 10.1001/jama.2013.4997.
5. Arandomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 2001, 119:1417-1436. Age-Related Eye Disease Study Research Group.
6. Allende A., Madigan M.C., Provis J.M. Endothelial cell proliferation in the choriocapillaris during human retinal differentiation. Br. J. Ophthalmol. 2006, 90:1046-1051. 10.1136/bjo.2006.092080.
7. Allikmets R., Shroyer N.F., Singh N., Seddon J.M., Lewis R.A., Bernstein P.S., Peiffer A., Zabriskie N.A., Li Y., Hutchinson A., Dean M., Lupski J.R., Leppert M. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997, 277:1805-1807.
8. Alm A., Bill A. The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol. Scand. 1972, 84:306-319. 10.1111/j.1748-1716.1972.tb05182.x.
9. Ames A. Energy requirements of CNS cells as related to their function and to their vulnerability to ischemia: a commentary based on studies on retina. Can. J. Physiol. Pharmacol. 1992, 70(Suppl.l):S158-S164.
10. Anderson D.H., Radeke M.J., Gallo N.B., Chapin E.A., Johnson P.T., Curletti C.R., Hancox L.S., Hu J., Ebright J.N., Malek G., Hauser M.A., Rickman C.B., Bok D., Hageman G.S., Johnson L.V. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res. 2010, 29:95-112. 10.1016/j.preteyeres.2009.11.003.
11. Chew E.Y., Clemons T.E., Bressler S.B., Elman M.J., Danis R.P., Domalpally A., Heier J.S., Kim J.E., Garfinkel, R Randomized trial of a home monitoring system for early detection of choroidal neovascularization Home Monitoring of the Eye (HOME) study. Ophthalmology 2014, 121:535-544. AREDS2-HOME Study Research Group. 10.1016/j.ophtha.2013.10.027.
12. Ardeljan D., Wang Y., Park S., Shen D., Chu X.K., Yu C.-R., Abu-Asab M., Tuo J., Eberhart C.G., Olsen T.W., Mullins R.F., White G., Wadsworth S., Scaria A., Chan C.-C. Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration. PLoS One 2014, 9:e95900. 10.1371/journal.pone.0095900.
13. Arnold J.J., Sarks S.H., Killingsworth M.C., Sarks J.P. Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 1995, 15:183-191.
14. Arora K.S., Jefferys J.L., Maul E.A., Quigley H.A. Choroidal thickness change after water drinking is greater in angle closure than in open angle eyes. Investig. Ophthalmol. Vis. Sci. 2012, 53:6393-6402. 10.1167/iovs.12-10224.
15. Awh C.C., Lane A.-M., Hawken S., Zanke B., Kim I.K. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Ophthalmology 2013, 120:2317-2323. 10.1016/j.ophtha.2013.07.039.
16. Bakall B., Folk J.C., Boldt H.C., Sohn E.H., Stone E.M., Russell S.R., Mahajan V.B. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Am. J. Ophthalmol. 2013, 156:15-22.e1. 10.1016/j.ajo.2013.02.017.
17. Barondes M., Pauleikhoff D., Chisholm I.C., Minassian D., Bird A.C. Bilaterality of drusen. Br. J. Ophthalmol. 1990, 74:180-182.
18. Bearelly S., Chau F.Y., Koreishi A., Stinnett S.S., Izatt J.A., Toth C.A. Spectral domain optical coherence tomography imaging of geographic atrophy margins. Ophthalmology 2009, 116:1762-1769. 10.1016/j.ophtha.2009.04.015.
19. Berenberg T.L., Metelitsina T.I., Madow B., Dai Y., Ying G.-S., Dupont J.C., Grunwald L., Brucker A.J., Grunwald J.E. The association between drusen extent and foveolar choroidal blood flow in age-related macular degeneration. Retina (Philadelphia, Pa.) 2012, 32:25-31. 10.1097/IAE.0b013e3182150483.
20. Bexborn F., Andersson P.O., Chen H., Nilsson B., Ekdahl K.N. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). Mol. Immunol. 2008, 45:2370-2379. 10.1016/j.molimm.2007.11.003.
21. Bhutto I.A., Baba T., Merges C., Juriasinghani V., McLeod D.S., Lutty G.A. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. Br. J. Ophthalmol. 2011, 95:1323-1330. 10.1136/bjo.2010.199216.
22. Biesemeier A., Biesemeier A., Taubitz T., Taubitz T., Julien S., Julien S., Yoeruek E., Yoeruek E., Schraermeyer U., Schraermeyer U. Neurobiol. Aging 2014, 1-42. Accepted Manuscript. 10.1016/j.neurobiolaging.2014.05.003.
23. Bird A.C., Bressler N.M., Bressler S.B., Chisholm I.H., Coscas G., Davis M.D., de Jong P.T., Klaver C.C., Klein B.E., Klein R. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv. Ophthalmol. 1995, 39:367-374.
24. Bird A.C., Phillips R.L., Hageman G.S. Geographic atrophy: a histopathological assessment. JAMA Ophthalmol. 2014, 132:338-345. 10.1001/jamaophthalmol.2013.5799.
25. Birke M.T., Lipo E., Adhi M., Birke K., Kumar-Singh R. AAV-mediated expression of human PRELP inhibits complement activation, choroidal neovascularization and deposition of membrane attack complex in mice. Gene Ther. 2014, 21:507-513. 10.1038/gt.2014.24.
26. Birol G., Wang S., Budzynski E., Wangsa-Wirawan N.D., Linsenmeier R.A. Oxygen distribution and consumption in the macaque retina. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1696-H1704. 10.1152/ajpheart.00221.2007.
27. Brechner R.J., Rosenfeld P.J., Babish J.D., Caplan S. Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file. Am. J. Ophthalmol. 2011, 151:887-895.e1. 10.1016/j.ajo.2010.11.017.
28. Bressler N.M., Doan Q.V., Varma R., Lee P.P., Suñer I.J., Dolan C., Danese M.D., Yu E., Tran I., Colman S. Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration. Arch. Ophthalmol. 2011, 129:709-717. 10.1001/archophthalmol.2011.140.
29. Brooks G.A., Brooks G.A., Hittelman K.J., Hittelman K.J., Faulkner J.A., Faulkner J.A., Beyer R.E., Beyer R.E. Temperature, skeletal muscle mitochondrial functions, and oxygen debt. Am. J. Physiol. 1971, 220:1053-1059.
30. Brown D.M., Kaiser P.K., Michels M., Soubrane G., Heier J.S., Kim R.Y., Sy J.P., Schneider S. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N.Engl. J. Med. 2006, 355:1432-1444. ANCHOR Study Group. 10.1056/NEJMoa062655.
31. Browning A.C., Halligan E.P., Stewart E.A., Swan D.C., Dove R., Samaranayake G.J., Amoaku W.M. Comparative gene expression profiling of human umbilical vein endothelial cells and ocular vascular endothelial cells. Br. J. Ophthalmol. 2012, 96:128-132. 10.1136/bjophthalmol-2011-300572.
32. Brunette J.R., Grassi M.A., Olivier P., Fingert J.H., Zaharia M., Scheetz T.E., Blondeau P., Roos B.R., Lafond G., Ritch R., West S.K., Kawase K., Shire A.M., Mullins R.F., Stone E.M. Rod-cone differences in response to retinal ischemia in rabbit. Doc. Ophthalmol. 1986, 63:359-365.
33. Burns M.S., Hartz M.J. The retinal pigment epithelium induces fenestration of endothelial cells invivo. Curr. Eye Res. 1992, 11:863-873.
34. Cao R., Brakenhielm E., Wahlestedt C., Thyberg J., Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6390-6395. 10.1073/pnas.101564798.
35. Casswell A.G., Kohen D., Bird A.C. Retinal pigment epithelial detachments in the elderly: classification and outcome. Br. J. Ophthalmol. 1985, 69:397-403.
36. Casten R.J., Rovner B.W. Update on depression and age-related macular degeneration. Curr. Opin. Ophthalmol. 2013, 24:239-243. 10.1097/ICU.0b013e32835f8e55.
37. Martin D.F., Maguire M.G., Ying G.-S., Grunwald J.E., Fine S.L., Jaffe G.J. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N.Engl. J. Med. 2011, 364:1897-1908. CATT Research Group. 10.1056/NEJMoa1102673.
38. Chan C.-C., Shen D., Zhou M., Ross R.J., Ding X., Zhang K., Green W.R., Tuo J. Human HtrA1 in the archived eyes with age-related macular degeneration. Trans. Am. Ophthalmol. Soc. 2007, 105:92-97. Discussion 97-8.
39. Chen H., Liu B., Lukas T.J., Neufeld A.H. The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS One 2008, 3:e2339. 10.1371/journal.pone.0002339.
40. Cherepanoff S., McMenamin P., Gillies M.C., Kettle E., Sarks S.H. Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br. J. Ophthalmol. 2010, 94:918-925. 10.1136/bjo.2009.165563.
41. Chew E.Y., Klein M.L., Clemons T.E., Agrón E., Ratnapriya R., Edwards A.O., Fritsche L.G., Swaroop A., Abecasis G.R. No clinically significant association between CFH and ARMS2 genotypes and response to Nutritional Supplements: AREDS report number 38. Ophthalmology 2014, Age-Related Eye Disease Study Research Group. 10.1016/j.ophtha.2014.05.008.
42. Christen W.G., Glynn R.J., Manson J.E., Ajani U.A., Buring J.E. Aprospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 1996, 276:1147-1151.
43. Chung S.E., Kang S.W., Lee J.H., Kim Y.T. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 2011, 118:840-845. 10.1016/j.ophtha.2010.09.012.
44. Clark S.J., Ridge L.A., Herbert A.P., Hakobyan S., Mulloy B., Lennon R., Würzner R., Morgan B.P., Uhrín D., Bishop P.N., Day A.J. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J.Immunol. 2013, 190:2049-2057. 10.4049/jimmunol.1201751.
45. Clow L.A., Raftos D.A., Gross P.S., Smith L.C. The sea urchin complement homologue, SpC3, functions as an opsonin. J.Exp. Biol. 2004, 207:2147-2155.
46. Coleman A.L., Yu F. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999. Ophthalmology 2008, 115:18-25. 10.1016/j.ophtha.2007.04.016.
47. Congdon N., O'Colmain B., Klaver C.C.W., Klein R., Muñoz B., Friedman D.S., Kempen J., Taylor H.R., Mitchell P. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 2004, 122:477-485. Eye Diseases Prevalence Research Group. 10.1001/archopht.122.4.477.
48. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14682-14687. 10.1073/pnas.222551899.
49. Cukras C., Agrón E., Klein M.L., Ferris F.L., Chew E.Y., Gensler G., Wong W.T. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: age-related eye disease study report no. 28. Ophthalmology 2010, 117:489-499. Age-Related Eye Disease Study Research Group. 10.1016/j.ophtha.2009.12.002.
50. Curcio C.A. Photoreceptor topography in ageing and age-related maculopathy. Eye (Lond.) 2001, 15:376-383. 10.1038/eye.2001.140.
51. Curcio C.A., Johnson M., Huang J.-D., Rudolf M. Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog. Retin. Eye Res. 2009, 28:393-422. 10.1016/j.preteyeres.2009.08.001.
52. Curcio C.A., Johnson M., Huang J.-D., Rudolf M. Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J.Lipid Res. 2010, 51:451-467. 10.1194/jlr.R002238.
53. Curcio C.A., Johnson M., Rudolf M., Huang J.-D. The oil spill in ageing Bruch membrane. Br. J. Ophthalmol. 2011, 95:1638-1645. 10.1136/bjophthalmol-2011-300344.
54. Curcio C.A., Messinger J.D., Sloan K.R., McGwin G., Medeiros N.E., Spaide R.F. Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina (Philadelphia, Pa.) 2013, 33:265-276. 10.1097/IAE.0b013e31827e25e0.
55. Curcio C.A., Millican C.L. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch. Ophthalmol. 1999, 117:329-339.
56. Curcio C.A., Presley J.B., Millican C.L., Medeiros N.E. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp. Eye Res. 2005, 80:761-775. 10.1016/j.exer.2004.09.017.
57. Curcio C.A., Sloan K.R., Kalina R.E., Hendrickson A.E. Human photoreceptor topography. J.Comp. Neurol. 1990, 292:497-523. 10.1002/cne.902920402.
58. Davis M.D., Gangnon R.E., Lee L.-Y., Hubbard L.D., Klein B.E.K., Klein R., Ferris F.L., Bressler S.B., Milton R.C. The age-related eye disease study severity scale for age-related macular degeneration: AREDS report No. 17. Arch. Ophthalmol. 2005, 123:1484-1498. Age-Related Eye Disease Study Group. 10.1001/archopht.123.11.1484.
59. Deangelis M.M., Ji F., Adams S., Morrison M.A., Harring A.J., Sweeney M.O., Capone A., Miller J.W., Dryja T.P., Ott J., Kim I.K. Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology 2008, 115:1209-1215.e7. 10.1016/j.ophtha.2007.10.032.
60. Degn S.E., Thiel S., Jensenius J.C. New perspectives on mannan-binding lectin-mediated complement activation. Immunobiology 2007, 212:301-311. 10.1016/j.imbio.2006.12.004.
61. Del Priore L.V., Kuo Y.-H., Tezel T.H. Age-related changes in human RPE cell density and apoptosis proportion in situ. Investig. Ophthalmol. Vis. Sci. 2002, 43:3312-3318.
62. Dewan A., Driscoll J.J., Zeng F., Liu M., Chowdhury R.D., Zhang M., Hartman S., Xu Y., Zhang S.S.-M., Xu H., Liu D.T.L., Zhao C., Tam P.O.S., Chan W.M., Lam D.S.C., Snyder M., Barnstable C., Pang C.P., Hoh J. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006, 314:989-992. 10.1126/science.1133807.
63. Do D.V., Pieramici D.J., van Lookeren Campagne M., Beres T., Friesenhahn M., Zhang Y., Strauss E.C. Aphase ia dose-escalation study of the anti-factor D monoclonal antibody fragment FCFD4514S in patients with geographic atrophy. Retina (Philadelphia, Pa.) 2014, 34:313-320. Phase Ia Investigators. 10.1097/IAE.0b013e3182979ddd.
64. Ducruet A.F., Zacharia B.E., Hickman Z.L., Grobelny B.T., Yeh M.L., Sosunov S.A., Connolly E.S. The complement cascade as a therapeutic target in intracerebral hemorrhage. Exp. Neurol. 2009, 219:398-403. 10.1016/j.expneurol.2009.07.018.
65. Ebrahem Q., Renganathan K., Sears J., Vasanji A., Gu X., Lu L., Salomon R.G., Crabb J.W., Anand-Apte B. Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13480-13484. 10.1073/pnas.0601552103.
66. Ebrahimi K.B., Fijalkowski N., Cano M., Handa J.T. Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration. J.Pathol. 2013, 229:729-742. 10.1002/path.4128.
67. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424. 10.1126/science.1110189.
68. Eisenhardt S.U., Habersberger J., Murphy A., Chen Y.-C., Woollard K.J., Bassler N., Qian H., Zur Muhlen von C., Hagemeyer C.E., Ahrens I., Chin-Dusting J., Bobik A., Peter K. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ. Res. 2009, 105:128-137. 10.1161/CIRCRESAHA.108.190611.
69. Eklund C.M. Proinflammatory cytokines in CRP baseline regulation. Adv. Clin. Chem. 2009, 48:111-136.
70. Antioxidant status and neovascular age-related macular degeneration. Arch. Ophthalmol. 1993, 111:104-109. Eye Disease Case-Control Study Group.
71. Ezzat M.K., Hann C.R., Vuk-Pavlovic S., Pulido J.S. Immune cells in the human choroid. Br. J. Ophthalmol. 2008, 92:976-980. 10.1136/bjo.2007.129742.
72. Fagerness J.A., Fagerness J.A., Maller J.B., Maller J.B., Neale B.M., Neale B.M., Reynolds R.C., Reynolds R.C., Daly M.J., Daly M.J., Seddon J.M., Seddon J.M. Variation near complement factor I is associated with risk of advanced AMD. Eur. J. Hum. Genet. 2009, 17:100-104. 10.1038/ejhg.2008.140.
73. Ferrara D., Mohler K.J., Waheed N., Adhi M., Liu J.J., Grulkowski I., Kraus M.F., Baumal C., Hornegger J., Fujimoto J.G., Duker J.S. En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy. Ophthalmology 2014, 121:719-726. 10.1016/j.ophtha.2013.10.014.
74. Ferris F.L., Davis M.D., Clemons T.E., Lee L.-Y., Chew E.Y., Lindblad A.S., Milton R.C., Bressler S.B., Klein R. Asimplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch. Ophthalmol. 2005, 123:1570-1574. Age-Related Eye Disease Study (AREDS) Research Group. 10.1001/archopht.123.11.1570.
75. Ferris F.L., Fine S.L., Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch. Ophthalmol. 1984, 102:1640-1642.
76. Ferris F.L., Wilkinson C.P., Bird A., Chakravarthy U., Chew E., Csaky K., Sadda S.R. Clinical classification of age-related macular degeneration. Ophthalmology 2013, 120:844-851. Beckman Initiative for Macular Research Classification Committee. 10.1016/j.ophtha.2012.10.036.
77. Fett A.L., Hermann M.M., Muether P.S., Kirchhof B., Fauser S. Immunohistochemical localization of complement regulatory proteins in the human retina. Histol. Histopathol. 2012, 27:357-364.
78. Filep J.G. Platelets affect the structure and function of C-reactive protein. Circ. Res. 2009, 105:109-111. 10.1161/CIRCRESAHA.109.202010.
79. Fine A.M., Elman M.J., Ebert J.E., Prestia P.A., Starr J.S., Fine S.L. Earliest symptoms caused by neovascular membranes in the macula. Arch. Ophthalmol. 1986, 104:513-514.
80. Fitzgerald M.E.C., Tolley E., Jackson B., Zagvazdin Y.S., Cuthbertson S.L., Hodos W., Reiner A. Anatomical and functional evidence for progressive age-related decline in parasympathetic control of choroidal blood flow in pigeons. Exp. Eye Res. 2005, 81:478-491. 10.1016/j.exer.2005.03.008.
81. Fleckenstein M., Charbel Issa P., Helb H.-M., Schmitz-Valckenberg S., Finger R.P., Scholl H.P.N., Loeffler K.U., Holz F.G. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2008, 49:4137-4144. 10.1167/iovs.08-1967.
82. Flyvbjerg A. Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily. Nat. Rev. Endocrinol. 2010, 6:94-101. 10.1038/nrendo.2009.266.
83. Folk J.C. Aging macular degeneration. Clinical features of treatable disease. Ophthalmology 1985, 92:594-602.
84. Ford K.M., Saint-Geniez M., Walshe T., Zahr A., D'Amore P.A. Expression and role of VEGF in the adult retinal pigment epithelium. Investig. Ophthalmol. Vis. Sci. 2011, 52:9478-9487. 10.1167/iovs.11-8353.
85. Forooghian F., Stetson P.F., Meyer S.A., Chew E.Y., Wong W.T., Cukras C., Meyerle C.B., Ferris F.L. Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema. Retina (Philadelphia, Pa.) 2010, 30:63-70. 10.1097/IAE.0b013e3181bd2c5a.
86. Forrester J.V. Macrophages eyed in macular degeneration. Nat. Med. 2003, 9:1350-1351. 10.1038/nm1103-1350.
87. Francis P.J., Appukuttan B., Simmons E., Landauer N., Stoddard J., Hamon S., Ott J., Ferguson B., Klein M., Stout J.T., Neuringer M. Rhesus monkeys and humans share common susceptibility genes for age-related macular disease. Hum. Mol. Genet. 2008, 17:2673-2680. 10.1093/hmg/ddn167.
88. Francis P.J., Hamon S.C., Ott J., Weleber R.G., Klein M.L. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J.Med. Genet. 2009, 46:300-307. 10.1136/jmg.2008.062737.
89. Friedlander M., Theesfeld C.L., Sugita M., Fruttiger M., Thomas M.A., Chang S., Cheresh D.A. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9764-9769.
90. Friedman D.S., O'Colmain B.J., Muñoz B., Tomany S.C., McCarty C., de Jong P.T.V.M., Nemesure B., Mitchell P., Kempen J. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 2004, 122:564-572. Eye Diseases Prevalence Research Group. 10.1001/archopht.122.4.564.
91. Friedman E., Ivry M., Ebert E., Glynn R., Gragoudas E., Seddon J. Increased scleral rigidity and age-related macular degeneration. Ophthalmology 1989, 96:104-108.
92. Friedman E., Smith T.R., Kuwabara T. Senile choroidal vascular patterns and drusen. Arch. Ophthalmol. 1963, 69:220-230.
93. Friedrich U., Myers C.A., Fritsche L.G., Milenkovich A., Wolf A., Corbo J.C., Weber B.H.F. Risk- and non-risk-associated variants at the 10q26 AMD locus influence ARMS2 mRNA expression but exclude pathogenic effects due to protein deficiency. Hum. Mol. Genet. 2011, 20:1387-1399. 10.1093/hmg/ddr020.
94. Fritsche L.G., Chen W., Schu M., Yaspan B.L., Yu Y., Thorleifsson G., Zack D.J., Arakawa S., Cipriani V., Ripke S., Igo R.P., Buitendijk G.H.S., Sim X., Weeks D.E., Guymer R.H., Merriam J.E., Francis P.J., Hannum G., Agarwal A., Armbrecht A.M., Audo I., Aung T., Barile G.R., Benchaboune M., Bird A.C., Bishop P.N., Branham K.E., Brooks M., Brucker A.J., Cade W.H., Cain M.S., Campochiaro P.A., Chan C.-C., Cheng C.-Y., Chew E.Y., Chin K.A., Chowers I., Clayton D.G., Cojocaru R., Conley Y.P., Cornes B.K., Daly M.J., Dhillon B., Edwards A.O., Evangelou E., Fagerness J., Ferreyra H.A., Friedman J.S., Geirsdottir A., George R.J., Gieger C., Gupta N., Hagstrom S.A., Harding S.P., Haritoglou C., Heckenlively J.R., Holz F.G., Hughes G., Ioannidis J.P.A., Ishibashi T., Joseph P., Jun G., Kamatani Y., Katsanis N., N Keilhauer C., Khan J.C., Kim I.K., Kiyohara Y., Klein B.E.K., Klein R., Kovach J.L., Kozak I., Lee C.J., Lee K.E., Lichtner P., Lotery A.J., Meitinger T., Mitchell P., Mohand-Saïd S., Moore A.T., Morgan D.J., Morrison M.A., Myers C.E., Naj A.C., Nakamura Y., Okada Y., Orlin A., Ortube M.C., Othman M.I., Pappas C., Park K.H., Pauer G.J.T., Peachey N.S., Poch O., Priya R.R., Reynolds R., Richardson A.J., Ripp R., Rudolph G., Ryu E., Sahel J.-A., Schaumberg D.A., Scholl H.P.N., Schwartz S.G., Scott W.K., Shahid H., Sigurdsson H., Silvestri G., Sivakumaran T.A., Smith R.T., Sobrin L., Souied E.H., Stambolian D.E., Stefansson H., Sturgill-Short G.M., Takahashi A., Tosakulwong N., Truitt B.J., Tsironi E.E., Uitterlinden A.G., van Duijn C.M., Vijaya L., Vingerling J.R., Vithana E.N., Webster A.R., Wichmann H.-E., Winkler T.W., Wong T.Y., Wright A.F., Zelenika D., Zhang M., Zhao L., Zhang K., Klein M.L., Hageman G.S., Lathrop G.M., Stefansson K., Allikmets R., Baird P.N., Gorin M.B., Wang J.J., Klaver C.C.W., Seddon J.M., Pericak-Vance M.A., Iyengar S.K., Yates J.R.W., Swaroop A., Weber B.H.F., Kubo M., Deangelis M.M., Léveillard T., Thorsteinsdottir U., Haines J.L., Farrer L.A., Heid I.M., Abecasis G.R. Seven new loci associated with age-related macular degeneration. Nat. Genet. 2013, 45:433-439. AMD Gene Consortium, 439e1-2. 10.1038/ng.2578.
95. Fritsche L.G., Loenhardt T., Janssen A., Fisher S.A., Rivera A., Keilhauer C.N., Weber B.H.F. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat. Genet. 2008, 40:892-896. 10.1038/ng.170.
96. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N.Engl. J. Med. 1999, 340:448-454. 10.1056/NEJM199902113400607.
97. Gass J.D., Jallow S., Davis B. Adult vitelliform macular detachment occurring in patients with basal laminar drusen. Am. J. Ophthalmol. 1985, 99:445-459.
98. Gass J.D.M. Drusen and disciform macular detachment and degeneration. Arch. Ophthalmol. 1973, 90:206-217.
99. Giani A., Pellegrini M., Carini E., Peroglio Deiro A., Bottoni F., Staurenghi G. The dark atrophy with indocyanine green angiography in Stargardt disease. Investig. Ophthalmol. Vis. Sci. 2012, 53:3999-4004. 10.1167/iovs.11-9258.
100. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., Cramer K., Neel J., Bergeron J., Barile G.R., Smith R.T., Hageman G.S., Dean M., Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 2006, 38:458-462. AMD Genetics Clinical Study Group. 10.1038/ng1750.
101. Gordon W.C., Bazan N.G. Mediator lipidomics in ophthalmology: targets for modulation in inflammation, neuroprotection and nerve regeneration. Curr. Eye Res. 2013, 38:995-1005. 10.3109/02713683.2013.827211.
102. Gotoh N., Nakanishi H., Hayashi H., Yamada R., Otani A., Tsujikawa A., Yamashiro K., Tamura H., Saito M., Saito K., Iida T., Matsuda F., Yoshimura N. ARMS2 (LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Am. J. Ophthalmol. 2009, 147:1037-1041. 1041.e1-2. 10.1016/j.ajo.2008.12.036.
103. Gotoh N., Yamashiro K., Nakanishi H., Saito M., Iida T., Yoshimura N. Haplotype analysis of the ARMS2/HTRA1 region in Japanese patients with typical neovascular age-related macular degeneration or polypoidal choroidal vasculopathy. Jpn. J. Ophthalmol. 2010, 54:609-614. 10.1007/s10384-010-0865-2.
104. Goverdhan S.V., Howell M.W., Mullins R.F., Osmond C., Hodgkins P.R., Self J., Avery K., Lotery A.J. Association of HLA class I and class II polymorphisms with age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2005, 46:1726-1734. 10.1167/iovs.04-0928.
105. Grassi M.A., Fingert J.H., Scheetz T.E., Roos B.R., Ritch R., West S.K., Kawase K., Shire A.M., Mullins R.F., Stone E.M. Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His. Hum. Mutat. 2006, 27:921-925. 10.1002/humu.20359.
106. Grassi M.A., Folk J.C., Scheetz T.E., Taylor C.M., Sheffield V.C., Stone E.M. Complement factor H polymorphism p.Tyr402His and cuticular Drusen. Arch. Ophthalmol. 2007, 125:93-97. 10.1001/archopht.125.1.93.
107. Grossniklaus H.E., Ling J.X., Wallace T.M., Dithmar S., Lawson D.H., Cohen C., Elner V.M., Elner S.G., Sternberg P. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis. 2002, 8:119-126.
108. Gu J., Pauer G.J.T., Yue X., Narendra U., Sturgill G.M., Bena J., Gu X., Peachey N.S., Salomon R.G., Hagstrom S.A., Crabb J.W. Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol. Cell. Proteomics 2009, 8:1338-1349. Clinical Genomic and Proteomic AMD Study Group. 10.1074/mcp.M800453-MCP200.
109. Gu X., Meer S.G., Miyagi M., Rayborn M.E., Hollyfield J.G., Crabb J.W., Salomon R.G. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J.Biol. Chem. 2003, 278:42027-42035. 10.1074/jbc.M305460200.
110. Gupta O.P., Brown G.C., Brown M.M. Age-related macular degeneration: the costs to society and the patient. Curr. Opin. Ophthalmol. 2007, 18:201-205. 10.1097/ICU.0b013e32810c8df4.
111. Guymer R.H., Bird A.C., Hageman G.S. Cytoarchitecture of choroidal capillary endothelial cells. Investig. Ophthalmol. Vis. Sci. 2004, 45:1660-1666.
112. Guymer R.H., Heon E., Lotery A.J., Munier F.L., Schorderet D.F., Baird P.N., McNeil R.J., Haines H., Sheffield V.C., Stone E.M. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch. Ophthalmol. 2001, 119:745-751.
113. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J.H., Silvestri G., Russell S.R., Klaver C.C.W., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., Allikmets R. Acommon haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7227-7232. 10.1073/pnas.0501536102.
114. Hageman G.S., Hancox L.S., Taiber A.J., Gehrs K.M., Anderson D.H., Johnson L.V., Radeke M.J., Kavanagh D., Richards A., Atkinson J., Meri S., Bergeron J., Zernant J., Merriam J., Gold B., Allikmets R., Dean M. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann. Med. 2006, 38:592-604. AMD Clinical Study Group.
115. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 2001, 20:705-732.
116. Hageman G.S., Zhu X.L., Waheed A., Sly W.S. Localization of carbonic anhydrase IV in a specific capillary bed of the human eye. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:2716-2720.
117. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421. 10.1126/science.1110359.
118. Hasegawa T., McLeod D.S., Bhutto I.A., Prow T., Merges C.A., Grebe R., Lutty G.A. The embryonic human choriocapillaris develops by hemo-vasculogenesis. Dev. Dyn. 2007, 236:2089-2100. 10.1002/dvdy.21231.
119. Hayreh S.S. Segmental nature of the choroidal vasculature. Br. J. Ophthalmol. 1975, 59:631-648.
120. Hayreh S.S. Invivo choroidal circulation and its watershed zones. Eye (Lond.) 1990, 4(Pt 2):273-289. 10.1038/eye.1990.39.
121. Heier J.S., Brown D.M., Chong V., Korobelnik J.-F., Kaiser P.K., Nguyen Q.D., Kirchhof B., Ho A., Ogura Y., Yancopoulos G.D., Stahl N., Vitti R., Berliner A.J., Soo Y., Anderesi M., Groetzbach G., Sommerauer B., Sandbrink R., Simader C., Schmidt-Erfurth U. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 2012, 119:2537-2548. VIEW 1 and VIEW 2 Study Groups. 10.1016/j.ophtha.2012.09.006.
122. Heon E., Buitendijk G.H.S., Piguet B., Rochtchina E., Munier F., Myers C., Sneed S.R., van Duijn C.M., Morgan C.M., Lee K.E., Forni S., Klein B.E.K., Pescia G., Meuer S.M., Schorderet D., de Jong P.T.V.M., Taylor C.M., Holliday E.G., Streb L.M., Tan A.G., Wiles C.D., Uitterlinden A.G., Nishimura D.Y., Sivakumaran T.S., Sheffield V.C., Attia J., Stone E.M., Hofman A., Mitchell P., Vingerling J.R., Iyengar S.K., Janssens A.C.J.W., Wang J.J., Klein R., Klaver C.C.W. Linkage of autosomal dominant radial drusen (malattia leventinese) to chromosome 2p16-21. Arch. Ophthalmol. 1996, 114:193-198.
123. Heurich M., Martínez-Barricarte R., Francis N.J., Roberts D.L., Rodríguez de Córdoba S., Morgan B.P., Harris C.L. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:8761-8766. 10.1073/pnas.1019338108.
124. Hogan M.J. Role of the retinal pigment epithelium in macular disease. Trans. Am. Acad. Ophthalmol. Otolaryngol. 1972, 76:64-80.
125. Hogan M.J., Alvarado J.A., Weddell J.E. Histology of the Human Eye. An Atlas and Textbook 1971, WB Saunders, Philadelphia, PA.
126. Hollyfield J.G., Bonilha V.L., Rayborn M.E., Yang X., Shadrach K.G., Lu L., Ufret R.L., Salomon R.G., Perez V.L. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 2008, 14:194-198. 10.1038/nm1709.
127. Holz F.G., Wolfensberger T.J., Piguet B., Gross-Jendroska M., Wells J.A., Minassian D.C., Chisholm I.H., Bird A.C. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 1994, 101:1522-1528.
128. Hosoya K.-I., Tomi M. Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. Biol. Pharm. Bull. 2005, 28:1-8.
129. Howard K.P., Klein B.E.K., Lee K.E., Klein R. Measures of body shape and adiposity as related to incidence of age-related eye diseases: observations from the Beaver Dam Eye Study. Investig. Ophthalmol. Vis. Sci. 2014, 55:2592-2598. 10.1167/iovs.13-13763.
130. Huang D., Swanson E.A., Lin C.P., Schuman J.S., Stinson W.G., Chang W., Hee M.R., Flotte T., Gregory K., Puliafito C.A. Optical coherence tomography. Science 1991, 254:1178-1181.
131. Huang J.-D., Curcio C.A., Johnson M. Morphometric analysis of lipoprotein-like particle accumulation in aging human macular Bruch's membrane. Investig. Ophthalmol. Vis. Sci. 2008, 49:2721-2727. 10.1167/iovs.07-1196.
132. Huang J.-D., Presley J.B., Chimento M.F., Curcio C.A., Johnson M. Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch. Exp. Eye Res. 2007, 85:202-218. 10.1016/j.exer.2007.03.011.
133. Hughes A.E., Orr N., Esfandiary H., Diaz-Torres M., Goodship T., Chakravarthy U. Acommon CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 2006, 38:1173-1177. 10.1038/ng1890.
134. Hyman L., Schachat A.P., He Q., Leske M.C. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related macular degeneration risk factors study group. Arch. Ophthalmol. 2000, 118:351-358.
135. Jablonski M.M., Iannaccone A., Reynolds D.H., Gallaher P., Allen S., Wang X., Reiner A. Age-related decline in VIP-positive parasympathetic nerve fibers in the human submacular choroid. Investig. Ophthalmol. Vis. Sci. 2007, 48:479-485. 10.1167/iovs.06-0972.
136. Jackson G.R., Scott I.U., Kim I.K., Quillen D.A., Iannaccone A., Edwards J.G. Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2014, 55:1427-1431. 10.1167/iovs.13-13745.
137. Jakobsdottir J., Conley Y.P., Weeks D.E., Mah T.S., Ferrell R.E., Gorin M.B. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am. J. Hum. Genet. 2005, 77:389-407. 10.1086/444437.
138. Jirarattanasopa P., Ooto S., Tsujikawa A., Yamashiro K., Hangai M., Hirata M., Matsumoto A., Yoshimura N. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. Ophthalmology 2012, 119:1666-1678. 10.1016/j.ophtha.2012.02.021.
139. Johnson L.V., Forest D.L., Banna C.D., Radeke C.M., Maloney M.A., Hu J., Spencer C.N., Walker A.M., Tsie M.S., Bok D., Radeke M.J., Anderson D.H. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18277-18282. 10.1073/pnas.1109703108.
140. Johnson L.V., Leitner W.P., Staples M.K., Anderson D.H. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp. Eye Res. 2001, 73:887-896. 10.1006/exer.2001.1094.
141. Johnson L.V., Ozaki S., Staples M.K., Erickson P.A., Anderson D.H. Apotential role for immune complex pathogenesis in drusen formation. Exp. Eye Res. 2000, 70:441-449. 10.1006/exer.1999.0798.
142. Johnson P.T., Betts K.E., Radeke M.J., Hageman G.S., Anderson D.H., Johnson L.V. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17456-17461. 10.1073/pnas.0606234103.
143. Jones A., Kumar S., Zhang N., Tong Z., Yang J.-H., Watt C., Anderson J., Amrita, Fillerup H., McCloskey M., Luo L., Yang Z., Ambati B., Marc R., Oka C., Zhang K., Fu Y. Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:14578-14583. 10.1073/pnas.1102853108.
144. Jylhävä J., Eklund C., Jylhä M., Hervonen A., Lehtimäki T., Karhunen P., Hurme M. Complement factor H 402His variant confers an increased mortality risk in Finnish nonagenarians: the vitality 90+ study. Exp. Gerontol. 2009, 44:297-299. 10.1016/j.exger.2008.10.006.
145. Kanagasingam Y., Bhuiyan A., Abràmoff M.D., Smith R.T., Goldschmidt L., Wong T.Y. Progress on retinal image analysis for age related macular degeneration. Prog. Retin. Eye Res. 2014, 38:20-42. 10.1016/j.preteyeres.2013.10.002.
146. Kanda A., Chen W., Othman M., Branham K.E.H., Brooks M., Khanna R., He S., Lyons R., Abecasis G.R., Swaroop A. Avariant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16227-16232. 10.1073/pnas.0703933104.
147. Kay C.N., Abràmoff M.D., Mullins R.F., Kinnick T.R., Lee K., Eyestone M.E., Chung M.M., Sohn E.H., Stone E.M. Three-dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with best vitelliform macular dystrophy. Arch. Ophthalmol. 2012, 130:357-364. 10.1001/archophthalmol.2011.363.
148. Keane P.A., Patel P.J., Liakopoulos S., Heussen F.M., Sadda S.R., Tufail A. Evaluation of age-related macular degeneration with optical coherence tomography. Surv. Ophthalmol. 2012, 57:389-414. 10.1016/j.survophthal.2012.01.006.
149. Khreiss T., József L., Potempa L.A., Filep J.G. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 2004, 109:2016-2022. 10.1161/01.CIR.0000125527.41598.68.
150. Kim D.Y., Fingler J., Zawadzki R.J., Park S.S., Morse L.S., Schwartz D.M., Fraser S.E., Werner J.S. Optical imaging of the chorioretinal vasculature in the living human eye. Proc. Natl. Acad. Sci. U. S. A. 2013, 10.1073/pnas.1307315110.
151. Klein M.L., Ferris F.L., Armstrong J., Hwang T.S., Chew E.Y., Bressler S.B., Chandra S.R. Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology 2008, 115:1026-1031. AREDS Research Group. 10.1016/j.ophtha.2007.08.030.
152. Klein M.L., Schultz D.W., Edwards A., Matise T.C., Rust K., Berselli C.B., Trzupek K., Weleber R.G., Ott J., Wirtz M.K., Acott T.S. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch. Ophthalmol. 1998, 116:1082-1088.
153. Klein R., Davis M.D., Magli Y.L., Segal P., Klein B.E., Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991, 98:1128-1134.
154. Klein R., Klein B.E.K., Knudtson M.D., Meuer S.M., Swift M., Gangnon R.E. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007, 114:253-262. 10.1016/j.ophtha.2006.10.040.
155. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389. 10.1126/science.1109557.
156. Kortvely E., Hauck S.M., Duetsch G., Gloeckner C.J., Kremmer E., Alge-Priglinger C.S., Deeg C.A., Ueffing M. ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. Investig. Ophthalmol. Vis. Sci. 2010, 51:79-88. 10.1167/iovs.09-3850.
157. Kubista K.E., Tosakulwong N., Wu Y., Ryu E., Roeder J.L., Hecker L.A., Baratz K.H., Brown W.L., Edwards A.O. Copy number variation in the complement factor H-related genes and age-related macular degeneration. Mol. Vis. 2011, 17:2080-2092.
158. Kurihara T., Westenskow P.D., Bravo S., Aguilar E., Friedlander M. Targeted deletion of Vegfa in adult mice induces vision loss. J.Clin. Investig. 2012, 122:4213-4217. 10.1172/JCI65157.
159. Laine M., Jarva H., Seitsonen S., Haapasalo K., Lehtinen M.J., Lindeman N., Anderson D.H., Johnson P.T., Järvelä I., Jokiranta T.S., Hageman G.S., Immonen I., Meri S. Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J.Immunol. 2007, 178:3831-3836.
160. Langford-Smith A., Keenan T.D.L., Clark S.J., Bishop P.N., Day A.J. The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?. J.Innate Immun. 2013, 10.1159/000356513.
161. Lau J.C.M., Linsenmeier R.A. Oxygen consumption and distribution in the Long-Evans rat retina. Exp. Eye Res. 2012, 102:50-58. 10.1016/j.exer.2012.07.004.
162. Lengyel I., Tufail A., Hosaini H.A., Luthert P., Bird A.C., Jeffery G. Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. Investig. Ophthalmol. Vis. Sci. 2004, 45:2886-2892. 10.1167/iovs.03-1083.
163. Li C., Fitzgerald M.E.C., Ledoux M.S., Gong S., Ryan P., Del Mar N., Reiner A. Projections from the hypothalamic paraventricular nucleus and the nucleus of the solitary tract to prechoroidal neurons in the superior salivatory nucleus: pathways controlling rodent choroidal blood flow. Brain Res. 2010, 1358:123-139. 10.1016/j.brainres.2010.08.065.
164. Li C.-M., Chung B.H., Presley J.B., Malek G., Zhang X., Dashti N., Li L., Chen J., Bradley K., Kruth H.S., Curcio C.A. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Investig. Ophthalmol. Vis. Sci. 2005, 46:2576-2586. 10.1167/iovs.05-0034.
165. Li C.-M., Presley J.B., Zhang X., Dashti N., Chung B.H., Medeiros N.E., Guidry C., Curcio C.A. Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy. J.Lipid Res. 2005, 46:628-640. 10.1194/jlr.M400428-JLR200.
166. Lindblad A.S., Lloyd P.C., Clemons T.E., Gensler G.R., Ferris F.L., Klein M.L., Armstrong J.R. Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch. Ophthalmol. 2009, 127:1168-1174. Age-Related Eye Disease Study Research Group. 10.1001/archophthalmol.2009.198.
167. Linsenmeier R.A. Effects of light and darkness on oxygen distribution and consumption in the cat retina. J.Gen. Physiol. 1986, 88:521-542.
168. Linsenmeier R.A., Braun R.D. Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J.Gen. Physiol. 1992, 99:177-197.
169. Linsenmeier R.A., Padnick-Silver L. Metabolic dependence of photoreceptors on the choroid in the normal and detached retina. Investig. Ophthalmol. Vis. Sci. 2000, 41:3117-3123.
170. Lipo E., Cashman S.M., Kumar-Singh R. Aurintricarboxylic acid inhibits complement activation, membrane attack complex, and choroidal neovascularization in a model of macular degeneration. Investig. Ophthalmol. Vis. Sci. 2013, 54:7107-7114. 10.1167/iovs.13-12923.
171. Liu A., Chang J., Lin Y., Shen Z., Bernstein P.S. Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration. J.Lipid Res. 2010, 51:3217-3229. 10.1194/jlr.M007518.
172. Liu A., Terry R., Lin Y., Nelson K., Bernstein P.S. Comprehensive and sensitive quantification of long-chain and very long-chain polyunsaturated fatty acids in small samples of human and mouse retina. J.Chromatogr. A 2013, 1307:191-200. 10.1016/j.chroma.2013.07.103.
173. Liu B., Wei L., Meyerle C., Tuo J., Sen H.N., Li Z., Chakrabarty S., Agrón E., Chan C.-C., Klein M.L., Chew E., Ferris F., Nussenblatt R.B. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J.Transl. Med. 2011, 9:1-12. 10.1186/1479-5876-9-111.
174. Lotery A.J., Munier F.L., Fishman G.A., Weleber R.G., Jacobson S.G., Affatigato L.M., Nichols B.E., Schorderet D.F., Sheffield V.C., Stone E.M. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2000, 41:1291-1296.
175. Lozanoska-Ochser B., Peakman M. Level of major histocompatibility complex class I expression on endothelium in non-obese diabetic mice influences CD8 T cell adhesion and migration. Clin. Exp. Immunol. 2009, 157:119-127. 10.1111/j.1365-2249.2009.03940.x.
176. Lutty G.A., Hasegawa T., Baba T., Grebe R., Bhutto I., McLeod D.S. Development of the human choriocapillaris. Eye 2010, 24:408-415. 10.1038/eye.2009.318.
177. Lutty G.A., McLeod D.S. Phosphatase enzyme histochemistry for studying vascular hierarchy, pathology, and endothelial cell dysfunction in retina and choroid. Vis. Res. 2005, 45:3504-3511. 10.1016/j.visres.2005.08.022.
178. Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial. Arch. Ophthalmol. 1982, 100:912-918. Macular Photocoagulation Study Group.
179. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Arch. Ophthalmol. 1993, 111:1200-1209. Macular Photocoagulation Study Group.
180. Malek G., Johnson L.V., Mace B.E., Saloupis P., Schmechel D.E., Rickman D.W., Toth C.A., Sullivan P.M., Bowes Rickman C. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11900-11905. 10.1073/pnas.0503015102.
181. Maller J., George S., Purcell S., Fagerness J., Altshuler D., Daly M.J., Seddon J.M. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat. Genet. 2006, 38:1055-1059. 10.1038/ng1873.
182. Mancini M.A., Frank R.N., Keirn R.J., Kennedy A., Khoury J.K. Does the retinal pigment epithelium polarize the choriocapillaris?. Investig. Ophthalmol. Vis. Sci. 1986, 27:336-345.
183. Mangione C.M., Gutierrez P.R., Lowe G., Orav E.J., Seddon J.M. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am. J. Ophthalmol. 1999, 128:45-53.
184. Mao M., Thedens D.R., Chang B., Harris B.S., Zheng Q.Y., Johnson K.R., Donahue L.R., Anderson M.G. The podosomal-adaptor protein SH3PXD2B is essential for normal postnatal development. Mamm. Genome 2009, 20:462-475. 10.1007/s00335-009-9210-9.
185. May C.A., Lütjen-Drecoll E. Choroidal ganglion cells in prenatal, young, and middle-aged human donor eyes. Curr. Eye Res. 2005, 30:667-672. 10.1080/02713680590968231.
186. May C.A., Neuhuber W., Lütjen-Drecoll E. Immunohistochemical classification and functional morphology of human choroidal ganglion cells. Investig. Ophthalmol. Vis. Sci. 2004, 45:361-367.
187. McGwin G., Hall T.A., Xie A., Owsley C. The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study. Br. J. Ophthalmol. 2005, 89:1166-1170. 10.1136/bjo.2005.067397.
188. McLeod D.S., Grebe R., Bhutto I., Merges C., Baba T., Lutty G.A. Relationship between RPE and choriocapillaris in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2009, 50:4982-4991. 10.1167/iovs.09-3639.
189. McLeod D.S., Lefer D.J., Merges C., Lutty G.A. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am. J. Pathol. 1995, 147:642-653.
190. McLeod D.S., Lutty G.A. High-resolution histologic analysis of the human choroidal vasculature. Investig. Ophthalmol. Vis. Sci. 1994, 35:3799-3811.
191. Melillo D., Sfyroera G., De Santis R., Graziano R., Marino R., Lambris J.D., Pinto M.R. First identification of a chemotactic receptor in an invertebrate species: structural and functional characterization of Ciona intestinalis C3a receptor. J.Immunol. 2006, 177:4132-4140.
192. Mrejen S., Spaide R.F. Optical coherence tomography: imaging of the choroid and beyond. Surv. Ophthalmol. 2013, 58:387-429. 10.1016/j.survophthal.2012.12.001.
193. Mullins R.F., Aptsiauri N., Hageman G.S. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye (Lond.) 2001, 15:390-395. 10.1038/eye.2001.142.
194. Mullins R.F., Dewald A.D., Streb L.M., Wang K., Kuehn M.H., Stone E.M. Elevated membrane attack complex in human choroid with high risk complement factor H genotypes. Exp. Eye Res. 2011, 93:3. 10.1016/j.exer.2011.06.015.
195. Mullins R.F., Grassi M.A., Skeie J.M. Glycoconjugates of choroidal neovascular membranes in age-related macular degeneration. Mol. Vis. 2005, 11:509-517.
196. Mullins R.F., Johnson M.N., Faidley E.A., Skeie J.M., Huang J. Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2011, 52:1606-1612. 10.1167/iovs.10-6476.
197. Mullins R.F., Russell S.R., Anderson D.H., Hageman G.S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000, 14:835-846.
198. Mullins R.F., Skeie J.M., Malone E.A., Kuehn M.H. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. Mol. Vis. 2006, 12:224-235.
199. Mullins R.F., Schoo D.P., Sohn E.H., Flamme-Wiese M.J., Workamelahu G., Johnston R.M., Wang K., Tucker B.A., Stone E.M. The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning. Am. J. Pathol. 2014, 184. 10.1016/j.ajpath.2014.07.017.
200. Mullins R.F., Sohn E.H. Bruch's Membrane: The critical boundary in macular degeneration. Age Related Macular Degeneration - the Recent Advances in Basic Research and Clinical Care 2012, 49-72. InTech, Rijeka, Croatia. G.-S. Ying (Ed.).
201. Murinello S., Mullins R.F., Lotery A.J., Perry V.H., Teeling J.L. Fcγ receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2014, 55:247-258. 10.1167/iovs.13-11821.
202. Newman A.M., Gallo N.B., Hancox L.S., Miller N.J., Radeke C.M., Maloney M.A., Cooper J.B., Hageman G.S., Anderson D.H., Johnson L.V., Radeke M.J. Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med. 2012, 4:16. 10.1186/gm315.
203. Nickla D.L., Wallman J. The multifunctional choroid. Prog. Retin. Eye Res. 2010, 29:144-168. 10.1016/j.preteyeres.2009.12.002.
204. Nielsen J.S., McNagny K.M. Novel functions of the CD34 family. J.Cell Sci. 2008, 121:3683-3692. 10.1242/jcs.037507.
205. Niemeijer M., van Ginneken B., Russell S.R., Suttorp-Schulten M.S.A., Abràmoff M.D. Automated detection and differentiation of drusen, exudates, and cotton-wool spots in digital color fundus photographs for diabetic retinopathy diagnosis. Investig. Ophthalmol. Vis. Sci. 2007, 48:2260-2267. 10.1167/iovs.06-0996.
206. Nishiguchi K.M., Yasuma T.R., Tomida D., Nakamura M., Ishikawa K., Kikuchi M., Ohmi Y., Niwa T., Hamajima N., Furukawa K., Terasaki H. C9-R95X polymorphism in patients with neovascular age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2012, 53:508-512. 10.1167/iovs.11-8425.
207. Nonaka M., Kimura A. Genomic view of the evolution of the complement system. Immunogenetics 2006, 58:701-713. 10.1007/s00251-006-0142-1.
208. Nonaka M., Yoshizaki F. Evolution of the complement system. Mol. Immunol. 2004, 40:897-902.
209. Nozaki M., Raisler B.J., Sakurai E., Sarma J.V., Barnum S.R., Lambris J.D., Chen Y., Zhang K., Ambati B.K., Baffi J.Z., Ambati J. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2328-2333. 10.1073/pnas.0408835103.
210. Okemefuna A.I., Nan R., Miller A., Gor J., Perkins S.J. Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations. J.Biol. Chem. 2010, 285:1053-1065. 10.1074/jbc.M109.044529.
211. Ormsby R.J., Ranganathan S., Tong J.C., Griggs K.M., Dimasi D.P., Hewitt A.W., Burdon K.P., Craig J.E., Hoh J., Gordon D.L. Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2008, 49:1763-1770. 10.1167/iovs.07-1297.
212. Otsuji T., McLeod D.S., Hansen B., Lutty G. Immunohistochemical staining and morphometric analysis of the monkey choroidal vasculature. Exp. Eye Res. 2002, 75:201-208.
213. Owsley C., Huisingh C., Jackson G.R., Curcio C.A., Szalai A.J., Dashti N., Clark M., Rookard K., McCrory M.A., Wright T.T., Callahan M.A., Kline L.B., Witherspoon C.D., McGwin G. Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health. Investig. Ophthalmol. Vis. Sci. 2014, 55:4776-4789. 10.1167/iovs.14-14502.
214. Owsley C., McGwin G., Jackson G.R., Kallies K., Clark M. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. Ophthalmology 2007, 114:1728-1735. 10.1016/j.ophtha.2006.12.023.
215. Parham P., Norman P.J., Abi-Rached L., Hilton H.G., Guethlein L.A. Review: immunogenetics of human placentation. Placenta 2012, 33(Suppl.l):S71-S80. 10.1016/j.placenta.2011.11.020.
216. Parver L.M., Auker C., Carpenter D.O. Choroidal blood flow as a heat dissipating mechanism in the macula. Am. J. Ophthalmol. 1980, 89:641-646.
217. Parver L.M. Temperature modulating action of choroidal blood flow. Eye (Lond.) 1991, 5(Pt 2):181-185. 10.1038/eye.1991.32.
218. Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102:2165-2168.
219. Pauleikhoff D., Spital G., Radermacher M., Brumm G.A., Lommatzsch A., Bird A.C. Afluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch. Ophthalmol. 1999, 117:1353-1358.
220. Pavlov N., Frendo J.-L., Guibourdenche J., Degrelle S.A., Evain-Brion D., Badet J. Angiogenin expression during early human placental development; association with blood vessel formation. Biomed. Res. Int. 2014, 2014:781632. 10.1155/2014/781632.
221. Penfold P.L., Killingsworth M.C., Sarks S.H. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch. Clin. Exp. Ophthalmol. 1985, 223:69-76.
222. Penfold P.L., Killingsworth M.C., Sarks S.H. Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Investig. Ophthalmol. Vis. Sci. 1986, 27:364-371.
223. Pennesi M.E., Neuringer M., Courtney R.J. Animal models of age related macular degeneration. Mol. Asp. Med. 2012, 33:487-509. 10.1016/j.mam.2012.06.003.
224. Pikuleva I.A., Curcio C.A. Cholesterol in the retina: the best is yet to come. Prog. Retin. Eye Res. 2014, 41:64-89. 10.1016/j.preteyeres.2014.03.002.
225. Pinto M.R., Melillo D., Giacomelli S., Sfyroera G., Lambris J.D. Ancient origin of the complement system: emerging invertebrate models. Adv. Exp. Med. Biol. 2007, 598:372-388. 10.1007/978-0-387-71767-8_26.
226. Quellec G., Russell S.R., Scheetz T.E., Stone E.M., Abràmoff M.D. Computational quantification of complex fundus phenotypes in age-related macular degeneration and Stargardt disease. Investig. Ophthalmol. Vis. Sci. 2011, 52:2976-2981. 10.1167/iovs.10-6232.
227. Quellec G., Russell S.R., Seddon J.M., Reynolds R., Scheetz T., Mahajan V.B., Stone E.M., Abràmoff M.D. Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2011, 52:9195-9206. 10.1167/iovs.10-6793.
228. Ramrattan R.S., van der Schaft T.L., Mooy C.M., de Bruijn W.C., Mulder P.G., de Jong P.T. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Investig. Ophthalmol. Vis. Sci. 1994, 35:2857-2864.
229. Richardson A.J., Islam F.M.A., Aung K.Z., Guymer R.H., Baird P.N. An intergenic region between the tagSNP rs3793917 and rs11200638 in the HTRA1 gene indicates association with age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2010, 51:4932-4936. 10.1167/iovs.09-5114.
230. Rifai N., Ridker P.M. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem. 2001, 47:403-411.
231. Rivera A. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum. Mol. Genet. 2005, 14:3227-3236. 10.1093/hmg/ddi353.
232. Rohrer B., Coughlin B., Bandyopadhyay M., Holers V.M. Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization. J.Ocul. Pharmacol. Ther. 2012, 28:402-409. 10.1089/jop.2011.0212.
233. Rosenfeld P.J., Brown D.M., Heier J.S., Boyer D.S., Kaiser P.K., Chung C.Y., Kim R.Y. Ranibizumab for neovascular age-related macular degeneration. N.Engl. J. Med. 2006, 355:1419-1431. MARINA Study Group. 10.1056/NEJMoa054481.
234. Rosenfeld P.J., Moshfeghi A.A., Puliafito C.A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg. Lasers Imaging 2005, 36:331-335.
235. Ruberti J.W., Curcio C.A., Millican C.L., Menco B.P.M., Huang J.-D., Johnson M. Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch's membrane. Investig. Ophthalmol. Vis. Sci. 2003, 44:1753-1759.
236. Rus H., Cudrici C., David S., Niculescu F. The complement system in central nervous system diseases. Autoimmunity 2006, 39:395-402. 10.1080/08916930600739605.
237. Russell S.R., Mullins R.F., Schneider B.L., Hageman G.S. Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. Am. J. Ophthalmol. 2000, 129:205-214.
238. Rutar M., Valter K., Natoli R., Provis J.M. Synthesis and propagation of complement C3 by microglia/monocytes in the aging retina. PLoS One 2014, 9:e93343. 10.1371/journal.pone.0093343.
239. Saint-Geniez M., Kurihara T., Sekiyama E., Maldonado A.E., D'Amore P.A. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18751-18756. 10.1073/pnas.0905010106.
240. Saint-Geniez M., Maldonado A.E., D'Amore P.A. VEGF expression and receptor activation in the choroid during development and in the adult. Investig. Ophthalmol. Vis. Sci. 2006, 47:3135-3142. 10.1167/iovs.05-1229.
241. Sakurai E., Taguchi H., Anand A., Ambati B.K., Gragoudas E.S., Miller J.W., Adamis A.P., Ambati J. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Investig. Ophthalmol. Vis. Sci. 2003, 44:2743-2749.
242. SanGiovanni J.P., Chew E.Y., Clemons T.E., Davis M.D., Ferris F.L., Gensler G.R., Kurinij N., Lindblad A.S., Milton R.C., Seddon J.M., Sperduto R.D. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS report no. 20. Arch. Ophthalmol. 2007, 125:671-679. Age-Related Eye Disease Study Research Group, Age-Related Eye Disease Study Research Group. 10.1001/archopht.125.5.671.
243. Sarks J.P., Sarks S.H., Killingsworth M.C. Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond.) 1988, 2(Pt 5):552-577. 10.1038/eye.1988.106.
244. Sarks S., Cherepanoff S., Killingsworth M., Sarks J. Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2007, 48:968-977. 10.1167/iovs.06-0443.
245. Sarks S.H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 1976, 60:324-341.
246. Sarks S.H. Changes in the region of the choriocapillaris in aging and degeneration. Proc. XXIII Int. Congr., Kyoto, 1979 1978, 228-232. K. Shimizu, J.A. Oosterhuis (Eds.).
247. Sarks S.H., Arnold J.J., Killingsworth M.C., Sarks J.P. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br. J. Ophthalmol. 1999, 83:358-368.
248. Schmidt S., Hauser M.A., Scott W.K., Postel E.A., Agarwal A., Gallins P., Wong F., Chen Y.S., Spencer K., Schnetz-Boutaud N., Haines J.L., Pericak-Vance M.A. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am. J. Hum. Genet. 2006, 78:852-864. 10.1086/503822.
249. Scholl H.P.N., Charbel Issa P., Walier M., Janzer S., Pollok-Kopp B., Börncke F., Fritsche L.G., Chong N.V., Fimmers R., Wienker T., Holz F.G., Weber B.H.F., Oppermann M. Systemic complement activation in age-related macular degeneration. PLoS One 2008, 3:e2593. 10.1371/journal.pone.0002593.
250. Schrödl F., Brehmer A., Neuhuber W.L., Nickla D. The autonomic facial nerve pathway in birds: a tracing study in chickens. Investig. Ophthalmol. Vis. Sci. 2006, 47:3225-3233. 10.1167/iovs.05-1279.
251. Schwartz D.M., Fingler J., Kim D.Y., Zawadzki R.J., Morse L.S., Park S.S., Fraser S.E., Werner J.S. Phase-variance optical coherence tomography: a technique for noninvasive angiography. Ophthalmology 2014, 121:180-187. 10.1016/j.ophtha.2013.09.002.
252. Schwartz S.G., Agarwal A., Kovach J.L., Gallins P.J., Cade W., Postel E.A., Wang G., Ayala-Haedo J., Spencer K.M., Haines J.L., Pericak-Vance M.A., Scott W.K. The ARMS2 A69S variant and bilateral advanced age-related macular degeneration. Retina 2012, 32:1486-1491. 10.1097/IAE.0b013e318240a540.
253. Schwedler S.B., Filep J.G., Galle J., Wanner C., Potempa L.A. C-reactive protein: a family of proteins to regulate cardiovascular function. Am. J. Kidney Dis. 2006, 47:212-222. 10.1053/j.ajkd.2005.10.028.
254. Seddon J.M., Afshari M.A., Sharma S., Bernstein P.S., Chong S., Hutchinson A., Petrukhin K., Allikmets R. Assessment of mutations in the best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy. Ophthalmology 2001, 108:2060-2067.
255. Seddon J.M., Ajani U.A., Sperduto R.D., Hiller R., Blair N., Burton T.C., Farber M.D., Gragoudas E.S., Haller J., Miller D.T. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994, 272:1413-1420.
256. Seddon J.M., Cote J., Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch. Ophthalmol. 2003, 121:1728-1737. 10.1001/archopht.121.12.1728.
257. Seddon J.M., Gensler G., Milton R.C., Klein M.L., Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004, 291:704-710. 10.1001/jama.291.6.704.
258. Seddon J.M., Gensler G., Rosner B. C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration. Ophthalmology 2010, 117:1560-1566. 10.1016/j.ophtha.2009.11.020.
259. Seddon J.M., George S., Rosner B., Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch. Ophthalmol. 2005, 123:774-782. 10.1001/archopht.123.6.774.
260. Seddon J.M., Ramrattan R.S., Willett W.C., van der Schaft T.L., Speizer F.E., Mooy C.M., Hankinson S.E., de Bruijn W.C., Mulder P.G., de Jong P.T. Aprospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996, 276:1141-1146.
261. Seddon J.M., Reynolds R., Yu Y., Rosner B. Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration. PLoS One 2014, 9:e87047. 10.1371/journal.pone.0087047.
262. Seddon J.M., Stevens B., Rosner B., Allen N.J., Sperduto R.D., Vazquez L.E., Yannuzzi L., Howell G.R., Haller J.A., Christopherson K.S., Blair N.P., Nouri N., Willett W., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W.M., Barres B.A. Dietary fat and risk for advanced age-related macular degeneration. Arch. Ophthalmol. 2001, 119:1191-1199.
263. Seddon J.M., Yu Y., Miller E.C., Reynolds R., Tan P.L., Gowrisankar S., Goldstein J.I., Triebwasser M., Anderson H.E., Zerbib J., Kavanagh D., Souied E., Katsanis N., Daly M.J., Atkinson J.P., Raychaudhuri S. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat. Genet. 2013, 10.1038/ng.2741.
264. Seitsonen S.P., Onkamo P., Peng G., Xiong M., Tommila P.V., Ranta P.H., Holopainen J.M., Moilanen J.A., Palosaari T., Kaarniranta K., Meri S., Immonen I.R., Järvelä I.E. Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration. PLoS One 2008, 3:e3833. 10.1371/journal.pone.0003833.
265. Sekine H., Takahashi M., Iwaki D., Fujita T. The role of MASP-1/3 in complement activation. Adv. Exp. Med. Biol. 2013, 735:41-53.
266. Sekiyama E., Saint-Geniez M., Yoneda K., Hisatomi T., Nakao S., Walshe T.E., Maruyama K., Hafezi-Moghadam A., Miller J.W., Kinoshita S., D'Amore P.A. Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity. FASEB J. 2012, 26:567-575. 10.1096/fj.11-184127.
267. Seth A., Cui J., To E., Kwee M., Matsubara J. Complement-associated deposits in the human retina. Investig. Ophthalmol. Vis. Sci. 2008, 49:743-750. 10.1167/iovs.07-1072.
268. Shaw P.X., Zhang L., Zhang M., Du H., Zhao L., Lee C., Grob S., Lim S.L., Hughes G., Lee J., Bedell M., Nelson M.H., Lu F., Krupa M., Luo J., Ouyang H., Tu Z., Su Z., Zhu J., Wei X., Feng Z., Duan Y., Yang Z., Ferreyra H., Bartsch D.-U., Kozak I., Zhang L., Lin F., Sun H., Feng H., Zhang K. Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:13757-13762. 10.1073/pnas.1121309109.
269. Skeie J.M., Fingert J.H., Russell S.R., Stone E.M., Mullins R.F. Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. Investig. Ophthalmol. Vis. Sci. 2010, 51:5336-5342. 10.1167/iovs.10-5322.
270. Skeie J.M., Mullins R.F. Macrophages in neovascular age-related macular degeneration: friends or foes?. Eye 2009, 23:747-755. 10.1038/eye.2008.206.
271. Skondra D., Papakostas T., Vavvas D.G. Enhanced depth imaging optical coherence tomography in age-related macular degeneration. Semin. Ophthalmol. 2012, 27:209-212. 10.3109/08820538.2012.708807.
272. Slakter J.S., Yannuzzi L.A., Guyer D.R., Sorenson J.A., Orlock D.A. Indocyanine-green angiography. Curr. Opin. Ophthalmol. 1995, 6:25-32.
273. Smailhodzic D., Klaver C.C., Klevering B.J., Boon C.J., Groenewoud J.M., Kirchhof B., Daha M.R., Hollander den A.I., Hoyng C.B. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology 2012, 119:339-346. 10.1016/j.ophtha.2011.07.056.
274. Sobrin L., Reynolds R., Yu Y., Fagerness J., Leveziel N., Bernstein P.S., Souied E.H., Daly M.J., Seddon J.M. ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am. J. Ophthalmol. 2011, 151:345-352.e3. 10.1016/j.ajo.2010.08.015.
275. Sohn E.H., Flamme-Wiese M.J., Whitmore S.S., Wang K., Tucker B.A., Mullins R.F. Loss of CD34 expression in aging muman choriocapillaris endothelial cells. PLoS One 2014, 9. 10.1371/journal.pone.0086538.
276. Sohn E.H., Khanna A., Tucker B.A., Abràmoff M.D., Stone E.M., Mullins R.F. Structural and biochemical analyses of choroidal thickness in human donor eyes. Investig. Ophthalmol. Vis. Sci. 2014, 10.1167/iovs.13-13754.
277. Sohn E.H., Mullins R.F., Stone E.M. Chapter 42-Macular dystrophies. Retina 2013, 852-890. W.B. Saunders, London. fifth ed. S.J. Ryan, S.R. Sadda, D.R. Hinton, A.P. Schachat, C.P. Wilkinson, P. Wiedemann (Eds.).
278. Soubrane G., Cruess A., Lotery A., Pauleikhoff D., Monès J., Xu X., Zlateva G., Buggage R., Conlon J., Goss T.F. Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study. Arch. Ophthalmol. 2007, 125:1249-1254. 10.1001/archopht.125.9.1249.
279. Spaide R.F. Age-related choroidal atrophy. Am. J. Ophthalmol. 2009, 147:801-810. 10.1016/j.ajo.2008.12.010.
280. Spaide R.F., Koizumi H., Pozzoni M.C., Pozonni M.C. Enhanced depth imaging spectral-domain optical coherence tomography. Am. J. Ophthalmol. 2008, 146:496-500. 10.1016/j.ajo.2008.05.032.
281. Spraul C.W., Lang G.E., Grossniklaus H.E. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 1996, 37:2724-2735.
282. Stan R.V., Tse D., Deharvengt S.J., Smits N.C., Xu Y., Luciano M.R., McGarry C.L., Buitendijk M., Nemani K.V., Elgueta R., Kobayashi T., Shipman S.L., Moodie K.L., Daghlian C.P., Ernst P.A., Lee H.-K., Suriawinata A.A., Schned A.R., Longnecker D.S., Fiering S.N., Noelle R.J., Gimi B., Shworak N.W., Carrière C. The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition. Dev. Cell 2012, 23:1203-1218. 10.1016/j.devcel.2012.11.003.
283. Starita C., Hussain A.A., Pagliarini S., Marshall J. Hydrodynamics of ageing Bruch's membrane: implications for macular disease. Exp. Eye Res. 1996, 62:565-572. 10.1006/exer.1996.0066.
284. Staurenghi G., Flower R.W. Clinical observations supporting a theoretical model of choriocapillaris blood flow in treatment of choroidal neovascularization associated with age-related macular degeneration. Am. J. Ophthalmol. 2002, 133:801-808.
285. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W.M., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178. 10.1016/j.cell.2007.10.036.
286. Stewart E.A., Samaranayake G.J., Browning A.C., Hopkinson A., Amoaku W.M. Comparison of choroidal and retinal endothelial cells: characteristics and response to VEGF isoforms and anti-VEGF treatments. Exp. Eye Res. 2011, 93:761-766. 10.1016/j.exer.2011.09.010.
287. Stitt A.W., O'Neill C.L., O'Doherty M.T., Archer D.B., Gardiner T.A., Medina R.J. Vascular stem cells and ischaemic retinopathies. Prog. Retin. Eye Res. 2011, 30:149-166. 10.1016/j.preteyeres.2011.02.001.
288. Stone E.M., Braun T.A., Russell S.R., Kuehn M.H., Lotery A.J., Moore P.A., Eastman C.G., Casavant T.L., Sheffield V.C. Missense variations in the fibulin 5 gene and age-related macular degeneration. N.Engl. J. Med. 2004, 351:346-353. 10.1056/NEJMoa040833.
289. Sugita A., Hamasaki M., Higashi R. Regional difference in fenestration of choroidal capillaries in Japanese monkey eye. Jpn. J. Ophthalmol. 1982, 26:47-52.
290. Takano T., Elimam H., Cybulsky A.V. Complement-mediated cellular injury. Semin. Nephrol. 2013, 33:586-601. 10.1016/j.semnephrol.2013.08.009.
291. Taubes G. Cardiovascular disease. Does inflammation cut to the heart ofthematter?. Science 2002, 296:242-245. 10.1126/science.296.5566.242.
292. Thompson B.R., Lobo S., Bernlohr D.A. Fatty acid flux in adipocytes: the in"s and out"s of fat cell lipid trafficking. Mol. Cell. Endocrinol. 2010, 318:24-33. 10.1016/j.mce.2009.08.015.
293. Thurman J.M., Holers V.M. The central role of the alternative complement pathway in human disease. J.Immunol. 2006, 176:1305-1310.
294. Tillett W.S., Frances T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J.Exp. Med. 1930, 52:561-571.
295. Tilton R.G., Miller E.J., Kilo C., Williamson J.R. Pericyte form and distribution in rat retinal and uveal capillaries. Investig. Ophthalmol. Vis. Sci. 1985, 26:68-73.
296. Tozer K., Roller A.B., Chong L.P., Sadda S., Folk J.C., Mahajan V.B., Russell S.R., Boldt H.C., Sohn E.H. Combination therapy for neovascular age-related macular degeneration refractory to anti-vascular endothelial growth factor agents. Ophthalmology 2013, 120:2029-2034. 10.1016/j.ophtha.2013.03.016.
297. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report 1. Arch. Ophthalmol. 1999, 117:1329-1345. Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group.
298. Tserentsoodol N., Sztein J., Campos M., Gordiyenko N.V. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol. Vis. 2006, 12:1306-1318.
299. Tucker B.A., Mullins R.F., Stone E.M. Stem cells for investigation and treatment of inherited retinal disease. Hum. Mol. Genet. 2014, 23:R9-R16. 10.1093/hmg/ddu124.
300. Tuo J., Ross R.J., Reed G.F., Yan Q., Wang J.J., Bojanowski C.M., Chew E.Y., Feng X., Olsen T.W., Ferris F.L., Mitchell P., Chan C.-C. The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples. Ophthalmology 2008, 115:1891-1898. 10.1016/j.ophtha.2008.05.021.
301. Tymms M.J. Sorsby's fundus dystrophy: what does TIMP3 tell us about general mechanisms underlying macular degeneration?. Clin. Exp. Optom. 1999, 82:124-129.
302. van Landingham S.W., Massof R.W., Chan E., Friedman D.S., Ramulu P.Y. Fear of falling in age-related macular degeneration. BMC Ophthalmol. 2014, 14:10. 10.1186/1471-2415-14-10.
303. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am. J. Ophthalmol. 2001, 131:541-560. Verteporfin In Photodynamic Therapy Study Group.
304. Vingerling J.R., Vingerling J.R., Hofman A., Hofman A., Grobbee D.E., Grobbee D.E., de Jong P.T., de Jong P.T. Age-related macular degeneration and smoking. Rotterdam Study. Arch. Ophthalmol. 1996, 114:1193-1196.
305. Vogt S.D., Barnum S.R., Curcio C.A., Read R.W. Distribution of complement anaphylatoxin receptors and membrane-bound regulators in normal human retina. Exp. Eye Res. 2006, 83:834-840. 10.1016/j.exer.2006.04.002.
306. Vogt S.D., Curcio C.A., Wang L., Li C.-M., McGwin G., Medeiros N.E., Philp N.J., Kimble J.A., Read R.W. Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy. Exp. Eye Res. 2011, 93:413-423. 10.1016/j.exer.2011.06.002.
307. Wallis R., Mitchell D.A., Schmid R., Schwaeble W.J., Keeble A.H. Paths reunited: initiation of the classical and lectin pathways of complement activation. Immunobiology 2010, 215:1-11. 10.1016/j.imbio.2009.08.006.
308. Wang G., Dubovy S.R., Kovach J.L., Schwartz S.G., Agarwal A., Scott W.K., Haines J.L., Pericak-Vance M.A. Variants at chromosome 10q26 locus and the expression of HTRA1 in the retina. Exp. Eye Res. 2013, 112:102-105. 10.1016/j.exer.2013.04.019.
309. Wang G., Scott W.K., Whitehead P., Court B.L., Kovach J.L., Schwartz S.G., Agarwal A., Dubovy S., Haines J.L., Pericak-Vance M.A. Anovel ARMS2 splice variant is identified in human retina. Exp. Eye Res. 2012, 94:187-191. 10.1016/j.exer.2011.11.005.
310. Wang G., Spencer K.L., Court B.L., Olson L.M., Scott W.K., Haines J.L., Pericak-Vance M.A. Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Investig. Ophthalmol. Vis. Sci. 2009, 50:3084-3090. 10.1167/iovs.08-3240.
311. Wang J.C., Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ. Res. 2012, 111:245-259. 10.1161/CIRCRESAHA.111.261388.
312. Wang L., Clark M.E., Crossman D.K., Kojima K., Messinger J.D., Mobley J.A., Curcio C.A. Abundant lipid and protein components of drusen. PLoS One 2010, 5:e10329. 10.1371/journal.pone.0010329.
313. Wang L., Li C.-M., Rudolf M., Belyaeva O.V., Chung B.H., Messinger J.D., Kedishvili N.Y., Curcio C.A. Lipoprotein particles of intraocular origin in human Bruch membrane: an unusual lipid profile. Investig. Ophthalmol. Vis. Sci. 2009, 50:870-877. 10.1167/iovs.08-2376.
314. Wang M.-Y., Ji S.-R., Bai C.-J., Kebir El D., Li H.-Y., Shi J.-M., Zhu W., Costantino S., Zhou H.-H., Potempa L.A., Zhao J., Filep J.G., Wu Y. Aredox switch in C-reactive protein modulates activation of endothelial cells. FASEB J. 2011, 25:3186-3196. 10.1096/fj.11-182741.
315. Wang M.Y., Rousseau J., Boisjoly H., Schmaltz H., Kergoat M.-J., Moghadaszadeh S., Djafari F., Freeman E.E. Activity limitation due to a fear of falling in older adults with eye disease. Investig. Ophthalmol. Vis. Sci. 2012, 53:7967-7972. 10.1167/iovs.12-10701.
316. Wang Q., Chappell R.J., Klein R., Eisner A., Klein B.E., Jensen S.C., Moss S.E. Pattern of age-related maculopathy in the macular area. The Beaver Dam Eye Study. Investig. Ophthalmol. Vis. Sci. 1996, 37:2234-2242.
317. Wang S., Linsenmeier R.A. Hyperoxia improves oxygen consumption in the detached feline retina. Investig. Ophthalmol. Vis. Sci. 2007, 48:1335-1341. 10.1167/iovs.06-0842.
318. Wang Y., Bian Z.-M., Yu W.-Z., Yan Z., Chen W.-C., Li X.-X. Induction of interleukin-8 gene expression and protein secretion by C-reactive protein in ARPE-19 cells. Exp. Eye Res. 2010, 91:135-142. 10.1016/j.exer.2010.02.008.
319. Wangsa-Wirawan N.D., Linsenmeier R.A. Retinal oxygen: fundamental and clinical aspects. Arch. Ophthalmol. 2003, 121:547-557. 10.1001/archopht.121.4.547.
320. Weber B.H., Vogt G., Pruett R.C., Stohr H., Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat. Genet. 1994, 8:352-356. 10.1038/ng1294-352.
321. Weeks D.E., Conley Y.P., Tsai H.J., Mah T.S., Rosenfeld P.J., Paul T.O., Eller A.W., Morse L.S., Dailey J.P., Ferrell R.E., Gorin M.B. Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions. Am. J. Ophthalmol. 2001, 132:682-692.
322. Weismann D., Hartvigsen K., Lauer N., Bennett K.L., Scholl H.P.N., Charbel Issa P., Cano M., Brandstätter H., Tsimikas S., Skerka C., Superti-Furga G., Handa J.T., Zipfel P.F., Witztum J.L., Binder C.J. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011, 478:76-81. 10.1038/nature10449.
323. Whitmore S.S., Braun T.A., Skeie J.M., Haas C.M., Sohn E.H., Stone E.M., Scheetz T.E., Mullins R.F. Altered gene expression in dry age-related macular degeneration suggests early loss of choroidal endothelial cells. Mol. Vis. 2013, 19:2274-2297.
324. Wolf-Schnurrbusch U.E.K., Enzmann V., Brinkmann C.K., Wolf S. Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Investig. Ophthalmol. Vis. Sci. 2008, 49:3095-3099. 10.1167/iovs.07-1460.
325. Yang Z., Camp N.J., Sun H., Tong Z., Gibbs D., Cameron D.J., Chen H., Zhao Y., Pearson E., Li X., Chien J., Dewan A., Harmon J., Bernstein P.S., Shridhar V., Zabriskie N.A., Hoh J., Howes K., Zhang K. Avariant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006, 314:992-993. 10.1126/science.1133811.
326. Yasuma T.R., Nakamura M., Nishiguchi K.M., Kikuchi M., Kaneko H., Niwa T., Hamajima N., Terasaki H. Elevated C-reactive protein levels and ARMS2/HTRA1 gene variants in subjects without age-related macular degeneration. Mol. Vis. 2010, 16:2923-2930.
327. Yates J.R.W., Sepp T., Matharu B.K., Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Hayward C., Morgan J., Wright A.F., Armbrecht A.M., Dhillon B., Deary I.J., Redmond E., Bird A.C., Moore A.T. Complement C3 variant and the risk of age-related macular degeneration. N.Engl. J. Med. 2007, 357:553-561. Genetic Factors in AMD Study Group. 10.1056/NEJMoa072618.
328. Yu W., Dong S., Zhao C., Wang H., Dai F., Yang J. Cumulative association between age-related macular degeneration and less studied genetic variants in PLEKHA1/ARMS2/HTRA1: a meta and gene-cluster analysis. Mol. Biol. Rep. 2013, 40:5551-5561. 10.1007/s11033-013-2656-6.
329. Yu Y., Triebwasser M.P., Wong E.K.S., Schramm E.C., Thomas B., Reynolds R., Mardis E.R., Atkinson J.P., Daly M., Raychaudhuri S., Kavanagh D., Seddon J.M. Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration. Hum. Mol. Genet. 2014, 10.1093/hmg/ddu226.
330. Yuan X., Gu X., Crabb J.S., Yue X., Shadrach K., Hollyfield J.G., Crabb J.W. Quantitative proteomics: comparison of the macular Bruch membrane/choroid complex from age-related macular degeneration and normal eyes. Mol. Cell Proteomics 2010, 9:1031-1046. 10.1074/mcp.M900523-MCP200.
331. Zalman L.S., Muller-Eberhard H.J. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement. Mol. Immunol. 1990, 27:533-537.
332. Zamora D.O., Riviere M., Choi D., Pan Y., Planck S.R., Rosenbaum J.T., David L.L., Smith J.R. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin. Mol. Vis. 2007, 13:2058-2065.
333. Zareparsi S., Branham K.E.H., Li M., Shah S., Klein R.J., Ott J., Hoh J., Abecasis G.R., Swaroop A. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am. J. Hum. Genet. 2005, 77:149-153. 10.1086/431426.
334. Zeng F., Zhang M., Xu Y., Xu H. ARMS2 interference leads to decrease of proinflammatory mediators. Graefes Arch. Clin. Exp. Ophthalmol. 2013, 251:2539-2544. 10.1007/s00417-013-2442-0.
335. Zeng S., Hernández J.J., Mullins R.F. Effects of antioxidant components of AREDS vitamins and zinc ions on endothelial cell activation: implications for macular degeneration. Investig. Ophthalmol. Vis. Sci. 2012, 53:1041-1047. 10.1167/iovs.11-8531.
336. Zhan X., Larson D.E., Wang C., Koboldt D.C., Sergeev Y.V., Fulton R.S., Fulton L.L., Fronick C.C., Branham K.E., Bragg-Gresham J., Jun G., Hu Y., Kang H.M., Liu D., Othman M., Brooks M., Ratnapriya R., Boleda A., Grassmann F., Strachwitz von C., Olson L.M., Buitendijk G.H.S., Hofman A., van Duijn C.M., Cipriani V., Moore A.T., Shahid H., Jiang Y., Conley Y.P., Morgan D.J., Kim I.K., Johnson M.P., Cantsilieris S., Richardson A.J., Guymer R.H., Luo H., Ouyang H., Licht C., Pluthero F.G., Zhang M.M., Zhang K., Baird P.N., Blangero J., Klein M.L., Farrer L.A., Deangelis M.M., Weeks D.E., Gorin M.B., Yates J.R.W., Klaver C.C.W., Pericak-Vance M.A., Haines J.L., Weber B.H.F., Wilson R.K., Heckenlively J.R., Chew E.Y., Stambolian D., Mardis E.R., Swaroop A., Abecasis G.R. Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat. Genet. 2013, 10.1038/ng.2758.
337. Zhang H., Morrison M.A., DeWan A., Adams S., Andreoli M., Huynh N., Regan M., Brown A., Miller J.W., Kim I.K., Hoh J., Deangelis M.M. The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration. BMC Med. Genet. 2008, 9:51. 10.1186/1471-2350-9-51.
338. Zhang L., Lee K., Niemeijer M., Mullins R.F., Sonka M., Abramoff M.D. Automated segmentation of the choroid from clinical SD-OCT. Investig. Ophthalmol. Vis. Sci. 2012, 53:7510-7519. 10.1167/iovs.12-10311.
339. Zhang L., Lim S.L., Du H., Zhang M., Kozak I., Hannum G., Wang X., Ouyang H., Hughes G., Zhao L., Zhu X., Lee C., Su Z., Zhou X., Shaw R., Geum D., Wei X., Zhu J., Ideker T., Oka C., Wang N., Yang Z., Shaw P.X., Zhang K. High temperature requirement factor A1 (HTRA1) gene regulates angiogenesis through transforming growth factor-β family member growth differentiation factor 6. J.Biol. Chem. 2012, 287:1520-1526. 10.1074/jbc.M111.275990.
340. Zipfel P.F., Skerka C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 2009, 9:729-740. 10.1038/nri2620.
341. Zweifel S.A., Imamura Y., Spaide T.C., Fujiwara T., Spaide R.F. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 2010, 117:1775-1781. 10.1016/j.ophtha.2010.01.027.
342. Zweifel S.A., Spaide R.F., Curcio C.A., Malek G., Imamura Y. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010, 117:303-312.e1. 10.1016/j.ophtha.2009.07.014.